search
Back to results

Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics

Primary Purpose

Intubation Complication

Status
Unknown status
Phase
Phase 4
Locations
Norway
Study Type
Interventional
Intervention
Lidocaine spray (2%)
Muscle Relaxant (Rocuronium)
No Muscle relaxant, no Lidocaine
Sponsored by
Ostfold Hospital Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Intubation Complication

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Scheduled elective surgery with general anesthesia and planned endotracheal intubation.

Exclusion Criteria:

  • ASA≥3,
  • 20>BMI<35
  • Allergy to local anesthetics or neuromuscular blocking agents.
  • The ASA physical status classification system is a system for assessing the fitness of patients before surgery. BMI is Body Mass Index measured in kilograms/square meter.

Sites / Locations

  • Ostfold Hospital Trust, MossRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Other

Other

Arm Label

Lidocaine spray

Muscle relaxant

No Muscle relaxant, no Lidocaine

Arm Description

Endotracheal lidocaine spray prior to intubation

Muscle relaxant prior to intubation

'No Muscle relaxant, no Lidocaine Control group

Outcomes

Primary Outcome Measures

Sore Throat postoperative. Assessment of complaints and changes in complaints
Postoperative sore throat, described 2 h and 24 h after extubation. If the patient has sore throat or is hoarse, the complaint is assessed on a VAS (Visual Analogue Scale) 1 - 10.
Intubation conditions directly after induction of anesthesia
Describes the intubation conditions: Jaw relaxation, resistance to laryngoscopy blade, the position and movement of vocal cords, the movement of limbs and coughing. Each variable rates as excellent, good or poor. Intubation conditions are many variables described once and should not be divided into several outcomes.
Hemodynamic parameters, change in HR (Heart Rate) is being assessed
Describes changes in HR (Heart Rate)
Hemodynamic parameters, change in BP (blood pressure) is being assessed
Describes changes in BP(Blood Pressure)

Secondary Outcome Measures

Full Information

First Posted
December 21, 2016
Last Updated
March 12, 2019
Sponsor
Ostfold Hospital Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT03031808
Brief Title
Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics
Official Title
Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant; Impact on Postoperative Sore Throat and Haemodynamics
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 31, 2017 (Actual)
Primary Completion Date
December 31, 2020 (Anticipated)
Study Completion Date
December 31, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ostfold Hospital Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
When a surgical procedure is performed under general anesthesia, the Airways are often secured With an endotracheal tube. Some patients experience sore throat thereafter. Studies have shown a reduction of these side effects when by use of muscle relaxants or a lidocain spray prior to the intubation. At Ostfold Hospital Trust, the investigators use one of the two methods or nothing. These methods will be studied systematically. Heart rate and blood pressure rise during the intubation procedure. The investigators will also study the differences between the groups.
Detailed Description
Post-operative sore throat and cough are common complications of endotracheal intubation and occurs in 30% to 70% of patients. Spraying with Lidocaine reduces this incident of postoperative sore Throat (POST). The use of neuromuscular blocking agents (NMBA) alone will also diminish the incidence of adverse postoperative upper airway symptoms. The use of topical Lidocaine is shown to reduce the cardiovascular responses during and after endotracheal intubation. Hypertension and tachycardia as a response to endotracheal intubation are probably of little consequence in healthy individuals. These reactions might though be harmful in patients with cardiovascular diseases. Postoperative sore throat is an undesired outcome for the patient. Topical or systemic pharmacological interventions is shown to reduce the POST. Our anesthetists practice very different. The investigators sometime use topical lidocaine 2% as a spray, sometime muscle relaxants and often nothing but propofol and remifentanil prior to laryngoscopy an endotracheal intubation. The objective of this study is to determine, whether the use of topical administered lidocaine, 2 %, has a better impact on POST compared with NMBA alone in general anesthesia with propofol and remifentanil. Patients receiving nothing but propofol and remifentanil will be the reference group. Assessment of the intubation conditions will be done according to a standard scheme The primary endpoint: Differences in the intubation conditions between the three groups. Cardiovascular responses caused by the laryngoscopy and intubation. The secondary endpoint: • Post operative upper airways symptoms. Power and Sample Size Calculator To detect a decrease in the incidence of pharyngolaryngeal symptoms from 60% to 45%, we calculated that we needed 150 patients per study arm (power of the study, 0,8; type I error, 0,05). 450 adult patients have to be scheduled for the study. The study is double blind, randomized: Group Topical lidocaine 4%: Group NMBA Control group Premedication: Paracetamol 2g General anaesthesia: TCI (Target Control of Infusion is a principle, an anesthesia infusion after protocol): Propofol and Remifentanil Surgical procedure: Not specified short lasting (<1 h) procedures The experienced anesthesiologist performing the intubating procedure will not be in the room until immediately before the intubation. Postoperatively: Oral paracetamol and codeine-fixed combination up to 1000 mg and 60 mg, respectively, every 6 h When nausea and vomiting occurs postoperatively, ondansetron 4 mg IV administers as the drug of first choice followed by droperidol 0,625 mg IV if the nausea/vomiting persists. Collected data: Patient characteristics inclusive smoke habits Intubation conditions according to the Copenhagen score Blood pressure prior to laryngoscopy and after 1, 3, 5, 7, 9, 11, 13 and 15 minutes, then every 15 min. Cuff pressure Pharyngolaryngeal discomfort 2 and 24 hours (telephone interview if released from hospital) after extubation

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intubation Complication

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Lidocaine spray
Arm Type
Other
Arm Description
Endotracheal lidocaine spray prior to intubation
Arm Title
Muscle relaxant
Arm Type
Other
Arm Description
Muscle relaxant prior to intubation
Arm Title
No Muscle relaxant, no Lidocaine
Arm Type
Other
Arm Description
'No Muscle relaxant, no Lidocaine Control group
Intervention Type
Drug
Intervention Name(s)
Lidocaine spray (2%)
Other Intervention Name(s)
Xylocain 2% Astra Zeneca
Intervention Description
Spraying trachea from 2 cm above the vocal cords and 5 cm down with a straw with multiple side holes
Intervention Type
Drug
Intervention Name(s)
Muscle Relaxant (Rocuronium)
Other Intervention Name(s)
Esmeron MSD
Intervention Description
After induction of anesthesia, the participants are given 0,6 mg/kg bodyweight intravenously.
Intervention Type
Other
Intervention Name(s)
No Muscle relaxant, no Lidocaine
Other Intervention Name(s)
Control group
Intervention Description
This group get general anesthesia without Rocuronium or Lidocaine
Primary Outcome Measure Information:
Title
Sore Throat postoperative. Assessment of complaints and changes in complaints
Description
Postoperative sore throat, described 2 h and 24 h after extubation. If the patient has sore throat or is hoarse, the complaint is assessed on a VAS (Visual Analogue Scale) 1 - 10.
Time Frame
2 h and 24 h after extubation
Title
Intubation conditions directly after induction of anesthesia
Description
Describes the intubation conditions: Jaw relaxation, resistance to laryngoscopy blade, the position and movement of vocal cords, the movement of limbs and coughing. Each variable rates as excellent, good or poor. Intubation conditions are many variables described once and should not be divided into several outcomes.
Time Frame
90 sec. after established general anesthesia
Title
Hemodynamic parameters, change in HR (Heart Rate) is being assessed
Description
Describes changes in HR (Heart Rate)
Time Frame
Prior to induction, then every second minute the next 15 minutes, thereafter every 15 minute until end of surgery (max. 2 h.)
Title
Hemodynamic parameters, change in BP (blood pressure) is being assessed
Description
Describes changes in BP(Blood Pressure)
Time Frame
Prior to induction, then every second minute the next 15 minutes, thereafter every 15 minute until end of surgery (max. 2 h.)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Scheduled elective surgery with general anesthesia and planned endotracheal intubation. Exclusion Criteria: ASA≥3, 20>BMI<35 Allergy to local anesthetics or neuromuscular blocking agents. The ASA physical status classification system is a system for assessing the fitness of patients before surgery. BMI is Body Mass Index measured in kilograms/square meter.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jan Sverre Vamnes, MD, Ph.D
Phone
+47 913 05 016
Email
jan.sverre.vamnes@so-hf.no
First Name & Middle Initial & Last Name or Official Title & Degree
Knut Inge Solbakk, MD
Phone
+47 909 33 106
Email
knut.inge.solbakk@so-hf.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Sverre Vamnes, MD, Ph.D.
Organizational Affiliation
Senior consultant
Official's Role
Study Chair
Facility Information:
Facility Name
Ostfold Hospital Trust, Moss
City
Grålum
State/Province
Ostfold
ZIP/Postal Code
1714
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jan Sverre Vamnes, MD, Ph.D.
Phone
+47 91608896
Email
janvam@so-hf.no
First Name & Middle Initial & Last Name & Degree
Knut Inge Solbakk, md
Phone
+47 90933106
Email
knisol@so-hf.no

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No sharing plan so far.
Citations:
PubMed Identifier
26082898
Citation
Banihashem N, Alijanpour E, Hasannasab B, Zarei A. Prophylactic Effects of Lidocaine or Beclomethasone Spray on Post-Operative Sore Throat and Cough after Orotracheal Intubation. Iran J Otorhinolaryngol. 2015 May;27(80):179-84.
Results Reference
background
PubMed Identifier
11094588
Citation
Blobner M, Mirakhur RK, Wierda JM, Wright PM, Olkkola KT, Debaene B, Pendeville P, Engbaek J, Rietbergen H, Sparr HJ. Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1. Br J Anaesth. 2000 Nov;85(5):724-31. doi: 10.1093/bja/85.5.724.
Results Reference
background
PubMed Identifier
17573390
Citation
Combes X, Andriamifidy L, Dufresne E, Suen P, Sauvat S, Scherrer E, Feiss P, Marty J, Duvaldestin P. Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth. 2007 Aug;99(2):276-81. doi: 10.1093/bja/aem147. Epub 2007 Jun 15.
Results Reference
background
PubMed Identifier
1167764
Citation
Domaoal AM, Weniger FC, Wolfson B. "Precurarization" using pancuronium. Anesth Analg. 1975 Jan-Feb;54(1):71-5. doi: 10.1213/00000539-197501000-00014.
Results Reference
background
PubMed Identifier
25999003
Citation
Doyle DJ. Airway anesthesia: theory and practice. Anesthesiol Clin. 2015 Jun;33(2):291-304. doi: 10.1016/j.anclin.2015.02.013.
Results Reference
background
PubMed Identifier
25109156
Citation
Kalil DM, Silvestro LS, Austin PN. Novel preoperative pharmacologic methods of preventing postoperative sore throat due to tracheal intubation. AANA J. 2014 Jun;82(3):188-97.
Results Reference
background
PubMed Identifier
2890365
Citation
Martin C, Bonneru JJ, Brun JP, Albanese J, Gouin F. Vecuronium or suxamethonium for rapid sequence intubation: which is better? Br J Anaesth. 1987 Oct;59(10):1240-4. doi: 10.1093/bja/59.10.1240.
Results Reference
background
PubMed Identifier
10084094
Citation
Mostafa SM, Murthy BV, Barrett PJ, McHugh P. Comparison of the effects of topical lignocaine spray applied before or after induction of anaesthesia on the pressor response to direct laryngoscopy and intubation. Eur J Anaesthesiol. 1999 Jan;16(1):7-10. doi: 10.1046/j.1365-2346.1999.00410.x.
Results Reference
background
PubMed Identifier
7741805
Citation
Koller ME, Husby P. High-dose vecuronium may be an alternative to suxamethonium for rapid-sequence intubation. Acta Anaesthesiol Scand. 1993 Jul;37(5):465-8. doi: 10.1111/j.1399-6576.1993.tb03747.x.
Results Reference
background
PubMed Identifier
23839320
Citation
Qi DY, Wang K, Zhang H, Du BX, Xu FY, Wang L, Zou Z, Shi XY. Efficacy of intravenous lidocaine versus placebo on attenuating cardiovascular response to laryngoscopy and tracheal intubation: a systematic review of randomized controlled trials. Minerva Anestesiol. 2013 Dec;79(12):1423-35. Epub 2013 Jul 9.
Results Reference
background
PubMed Identifier
19588349
Citation
Tanaka Y, Nakayama T, Nishimori M, Sato Y, Furuya H. Lidocaine for preventing postoperative sore throat. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004081. doi: 10.1002/14651858.CD004081.pub2.
Results Reference
background
PubMed Identifier
8904261
Citation
Viby-Mogensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS, Koscielniak-Nielsen Z, Skovgaard LT, Ostergaard D. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand. 1996 Jan;40(1):59-74. doi: 10.1111/j.1399-6576.1996.tb04389.x.
Results Reference
background

Learn more about this trial

Comparison of Two Induction Regimens Using Topical Lidocaine or Muscle Relaxant on Sore Throat and Hemodynamics

We'll reach out to this number within 24 hrs